Skip to Content

GG 637 GG 637 (Lansoprazole delayed release 15 mg)

Pill imprint GG 637 GG 637 has been identified as Lansoprazole delayed release 15 mg.

Lansoprazole is used in the treatment of barrett's esophagus; gerd; erosive esophagitis; helicobacter pylori infection; gastritis/duodenitis (and more), and belongs to the drug class proton pump inhibitors. There is no proven risk in humans during pregnancy. Lansoprazole 15 mg is not a controlled substance under the Controlled Substance Act (CSA).

Lansoprazole delayed release
Imprint:
GG 637 GG 637
Strength:
15 mg
Color:
White
Shape:
Capsule-shape
Availability:
Rx and/or OTC
Drug Class:
Proton pump inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Sandoz Pharmaceuticals Inc
National Drug Code (NDC):
00781-2147
Inactive Ingredients:
carrageenan
silicon dioxide
carnauba wax
hypromelloses
magnesium carbonate
methacrylic acid - ethyl acrylate copolymer (1:1) type a
polyethylene glycol 400
potassium chloride
sucrose
magnesium silicate
titanium dioxide
FD&C Blue No. 2
glycerol monooleate
shellac
ferric oxide yellow
corn starch

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide